NGM BIOPHARMACEUTICALS INC Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Ngm Biopharmaceuticals Inc quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Ngm Biopharmaceuticals Inc Return On Equity for the quarter ending December 31, 2023 was -77.9 %, a 37.4% decline year-over-year.
  • Ngm Biopharmaceuticals Inc annual Return On Equity for 2023 was -77.9 %, a 37.4% decline from 2022.
  • Ngm Biopharmaceuticals Inc annual Return On Equity for 2022 was -56.7 %, a 72.1% decline from 2021.
  • Ngm Biopharmaceuticals Inc annual Return On Equity for 2021 was -32.9 %, a 5.51% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -77.9 -21.2 -37.4% Jan 1, 2023 Dec 31, 2023
2022 -56.7 -23.7 -72.1% Jan 1, 2022 Dec 31, 2022
2021 -32.9 +1.92 +5.51% Jan 1, 2021 Dec 31, 2021
2020 -34.8 -15.8 -82.5% Jan 1, 2020 Dec 31, 2020
2019 -19.1 -19.5 -4748% Jan 1, 2019 Dec 31, 2019
2018 0.41 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.